Maravai Lifesciences Holdings (MRVI) Treasury Shares (2020 - 2025)

Maravai Lifesciences Holdings' Treasury Shares history runs 6 years deep, the most recent figure standing at $11.6 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 46.1% year-over-year to $11.6 million in Q4 2025; TTM through Dec 2025 was $11.6 million, a 46.1% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 46.1% from the prior year.
• Treasury Shares climbed to $11.6 million in Q4 2025 per MRVI's latest filing, from $7.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $11.6 million in Q4 2025 and bottomed at $90000.0 in Q4 2021.
• The 5-year median for Treasury Shares is $3.9 million (2023), against an average of $5.0 million.
• Across the five-year window, Treasury Shares plunged 74.21% in 2021 and soared 1378.89% in 2022, its largest moves.
• Year by year, Treasury Shares stood at $90000.0 in 2021, then surged by 1378.89% to $1.3 million in 2022, then surged by 196.32% to $3.9 million in 2023, then surged by 101.47% to $7.9 million in 2024, then soared by 46.1% to $11.6 million in 2025.
• Per Business Quant, the three latest MRVI Treasury Shares figures stand at $11.6 million (Q4 2025), $7.9 million (Q4 2024), and $3.9 million (Q4 2023).